![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2000, American Society for Microbiology The tprK Gene Is Heterogeneous among Treponema pallidum Strains and Has Multiple Alleles Department of Medicine, University of Washington, Seattle, Washington 98195 Editor: D. L. Burns *Corresponding author. Mailing address: Harborview Medical Center, 325 Ninth Ave., Box 359779, Seattle, WA 98104-2499. Phone: (206) 341-5364. Fax: (206) 341-5363. E-mail: acentur/at/u.washington.edu. Received August 2, 1999; Revisions requested September 8, 1999; Accepted November 1, 1999. This article has been cited by other articles in PMC.Abstract We have previously shown that the TprK antigen of T. pallidum, Nichols strain, is predominantly expressed in treponemes obtained 10 days after infection and that the hydrophilic domain of TprK is a target of opsonic antibodies and confers significant protection against homologous challenge. The T. pallidum genome sequence reported the presence of a single copy of the tprK gene in the Nichols strain. In the present study we demonstrate size heterogeneity in the central portions of the TprK hydrophilic domains of 14 treponemal isolates. Sequence analysis of the central domains and the complete open reading frames (ORFs) of the tprK genes confirms this heterogeneity. Further, multiple tprK sequences were found in the Nichols-defined tprK locus in three isolates (Sea 81-4, Bal 7, and Bal 73-1). In contrast, only a single tprK sequence could be identified in this locus in the Nichols strain. Alignment of the DNA and deduced amino acid sequences of the whole tprK ORFs shows the presence of seven discrete variable domains flanked by highly conserved regions. We hypothesize that these heterogeneous regions may be involved in antigenic heterogeneity and, in particular, evasion of the immune response. The presence of different tprK alleles in the tprK locus strongly suggests the existence of genetically different subpopulations within treponemal isolates. Treponema pallidum subsp. pallidum (referred to here as simply T. pallidum), the etiologic agent of syphilis, causes a lifelong chronic infection in untreated individuals. Syphilis has three distinct clinical stages: the primary localized chancre, the disseminated secondary stage, and the late tertiary phase. The host develops rapid and vigorous humoral and cellular immune responses against T. pallidum which eliminate most of the treponemes from primary and secondary lesions. However, a few treponemes evade the immune responses and lead to persistent infection. It has been shown that phagocytosis by macrophages is the major clearance mechanism of T. pallidum from early lesions (20, 21). Rabbit macrophages are able to ingest and kill T. pallidum in vitro, but efficient phagocytosis requires specific opsonic antibodies (2), presumably directed against surface exposed antigens. No outer membrane antigens have yet been definitively identified in T. pallidum (25). Unlike gram-negative bacteria such as Escherichia coli, the outer membrane of T. pallidum is very fragile (12) and is easily disrupted by physical manipulation. This characteristic has resulted in misidentification of highly immunogenic periplasmic lipoproteins as surface exposed antigens (24), although these molecules are now thought to be anchored to the periplasmic leaflet of the cytoplasmic membrane (11, 25–27). Freeze fracture electron microscopy studies reveal a very limited number of surface-exposed transmembrane proteins localized in the outer membrane (28, 32). These have been called Tromps (treponemal rare outer membrane proteins) because of their extraordinarily low density, and it has been proposed that the antibody causes the aggregation of Tromps in the intact treponeme (6, 19). Two single-copy genes have been proposed to encode rare outer membrane proteins (3, 5, 10). Tromp1 is homologous to periplasmic binding proteins of ABC transport systems (17), and its outer membrane location and ion channel activity are in dispute (1, 4, 13, 18). Tromp2 is a 28-kDa protein, but its outer membrane localization has not yet been confirmed independently. Recent studies have reported that the glycerophosphodiester phosphodiesterase (Gpd) of T. pallidum is a lipoprotein that binds the Fc fragment of human immunoglobulin G and has immunoprotective capacity against homologous challenge in experimental syphilis, suggesting that this molecule may be surface exposed (7). A second study proposes that Gpd is a periplasmic protein associated with the peptidoglycan-cytoplasmic membrane complex (29). Thus, the identities of surface-exposed molecules in T. pallidum are still undetermined. A new 12-member gene family, termed tpr, has been recently identified in the Nichols strain of T. pallidum (8, 16, 30). The predicted amino acid sequences of the tpr genes (tprA through tprL) have homology with the major sheath protein (Msp) antigen of Treponema denticola, which is reported to be surface exposed, to be involved in cell attachment, and to have porin activity (14, 15). Three tpr subfamilies (I, II, and III) can be identified by their predicted amino acid homology (8). Although there is some homology in the amino acid sequences among all Tpr proteins, comparison of the amino acid sequences of the members of subfamilies I and II shows that the NH2- and COOH-terminal regions are conserved, whereas the central domains are variable in terms of sequence and length. Subfamily III is composed of five members that are comparatively poorly homologous to each other or to the other Tpr proteins but that still retain small areas of conservation. Using PSORT analysis, three Tpr proteins are predicted to be located in the outer membrane of T. pallidum: two from subfamily I (TprF and TprI) and one from subfamily III (TprK) (8). Recent studies have demonstrated that the Nichols TprK antigen, encoded by a single-copy gene in the Nichols strain, is preferentially expressed during infection, is the target of opsonic antibodies, and induces a partially protective immune response (8). We report in this study the existence of multiple, heterogeneous tprK alleles in T. pallidum isolates other than the Nichols strain, while only a single allele is detectable in the Nichols strain. MATERIALS AND METHODS Treponemal strains and DNA extraction. All T. pallidum isolates were propagated in New Zealand White rabbits (22). This project was approved by the University of Washington Animal Care Committee, and animals were handled according to institutional guidelines. The treponemal isolates used in this study were provided by Paul Hardy and Ellen Nell (Johns Hopkins University), James Miller (University of California, Los Angeles), and Peter Perine (Centers for Disease Control and Prevention) or else were isolated at the University of Washington (Table 1). Nichols strain, the standard laboratory strain, has been maintained in rabbits since its isolation in 1912. In contrast, all other isolates have been kept as frozen stocks with limited passage in rabbits.
Suspensions of each treponemal strain were collected, taking careful precautions to avoid cross-contamination, and spun in a microcentrifuge at 12,000 × g for 30 min at 4°C. The pellet was resuspended in 200 μl of 1× lysis buffer (10 mM Tris, pH 8.0; 0.1 M EDTA; 0.5% sodium dodecyl sulfate), and DNA was extracted by using the Qiagen Kit for genomic DNA extraction (Qiagen, Inc., Chatsworth, Calif.) as described elsewhere (9). Each strain was handled separately under stringent PCR-clean conditions. Primers and PCR amplification of central domains of tprK genes. The DNA sequences of the Nichols strain tprK gene (TP0897) and its flanking regions were obtained from the published T. pallidum genome sequence (16). A set of primers, tprK-S and tprK-As (Table 2 and Fig. Fig.1),1
Identification of tprK alleles in T. pallidum strains located in the Nichols tprK locus. To identify the tprK sequences of the Bal 7, Bal 73-1, Sea 81-4, and the Nichols isolates that are located in the same locus as the Nichols tprK described in the T. pallidum genome, we used the primers F5-S and F3-As designed in the 5′ and 3′ tprK flanking regions (Table 2). These oligonucleotides amplify DNA fragments encompassing the 5′-flanking region, the tprK open reading frame (ORF) and the 3′-flanking region (Fig. (Fig.1).1 Amplification of the 3′ end of the Nichols tprK gene and the 3′-flanking region. In order to rule out possible PCR or sequencing artifacts and to confirm our findings, amplicons from independent PCR reactions encompassing the second half of the tprK gene and its 3′-flanking region were obtained from the Nichols strain maintained in our laboratory. We used the tprK-S and the F3-As primers (Table 2) under the same PCR conditions as those described above. The size of the amplicons was confirmed by agarose gel electrophoresis, and an aliquot was used for direct cloning and sequencing. Cloning and sequencing. After PCR amplification, the products from the different PCR reactions described above were directly cloned into the TOPOII T/A cloning vector (Invitrogen, Carlsbad, Calif.) according to the manufacturer's instructions. Double-stranded plasmid DNA from multiple clones from Bal 7, Bal 73-1, Sea 81-4, and the Nichols isolates containing inserts of tprK internal DNA fragments and from clones from amplicons encompassing the 5′ and 3′ flanking regions plus the tprK ORF (Fig. (Fig.1)1 RESULTS Identification of multiple tprK alleles in other isolates of T. pallidum. PCR amplification of the 13 T. pallidum isolates (Table 1) and the Nichols strain with the tprK-S and tprK-As primers resulted in amplicons of different molecular weights and, in some isolates, the presence of two different size amplicons as determined by high-resolution agarose gel electrophoresis (Fig. (Fig.2).2
Alignment of the DNA (not shown) and deduced amino acid sequences (Fig. (Fig.3)3
Identification of different tprK alleles in the Nichols tprK locus in street isolates. The single-copy tprK gene (TP0897) of the Nichols strain is located in the T. pallidum genome (16) at base positions 975833 through 974319, flanked at its 5′ and 3′ ends by a putative ATP-dependent nuclease (TP0898) and hypothetical proteins (TP0896 and TP0895, respectively). As a first attempt to elucidate the genetic arrangement of the multiple tprK alleles in other isolates, we amplified the tprK sequence(s) located in the Nichols tprK locus (the 5′- and 3′-flanking regions plus the tprK ORF) in other isolates by using the F5-S and F3-As primers (Fig. (Fig.1).1
The predicted amino acid sequences of the tprK whole ORFs of the Nichols isolate from the T. pallidum genome sequence and from the Nichols strain maintained in our laboratory are almost completely identical. However, they differ slightly in ORF size, giving 505 amino acids for the genome Nichols and 503 amino acids for the Seattle Nichols strain. The products of two independent PCR reactions and sequences of multiple clones consistently yielded the same tprK ORF sequence from our Nichols strain. The differences between the two Nichols sequences are located in the V1 variable region (three amino acid deletions and two amino acid changes in our sequence), the V3 region (one amino acid change), and the V6 region (one amino acid deletion and two amino acid changes in the genome sequence) and in the V7 variable domain (three amino acid changes) (Fig. (Fig.44 Analysis of the DNA alignments of the 3′-flanking region of tprK in the genome Nichols strain and in Sea 81-4 shows the presence of two putative hairpin structures (Fig. (Fig.5)5
DISCUSSION T. pallidum is cleared from early syphilis lesions by macrophage-mediated phagocytosis; this activity is facilitated by the presence of opsonic antibody. We recently showed that antibodies directed against a large hydrophilic region of TprK are opsonic for T. pallidum in vitro and that immunization with this recombinant peptide is partially protective against homologous infection (8). Because of the potential importance of TprK in the functional and protective immune responses in syphilis, we have investigated its structure in other T. pallidum isolates. This report demonstrates the existence of multiple alleles of tprK within isolates and heterogeneity in tprK sequences among isolates. Our DNA sequences are derived from PCR-amplified products, and we recognize that some random sequence artifact may occur during PCR amplification. However, several findings suggest that the heterogeneity that we have identified is not artifactual. First, all 19 clones (derived from four independent PCR amplifications) containing inserts of the Nichols strain yielded identical sequences in this region. Second, identical tprK sequences were obtained from independent PCR amplifications of multiple strains (not included in this study). Finally, the observed heterogeneity in tprK sequence, including deletions and insertions, does not introduce frameshifts and stops in the ORF. Sequence comparison of the tprK DNA and their predicted amino acid sequences shows heterogeneous domains flanked by highly conserved regions. Sequence alignments between the tpr variable regions and the T. pallidum genome failed to identify regions of identity elsewhere in the genome. Close analysis reveals that some tprK genes encode nearly identical proteins, such as the internal TprK fragments Sea 81-4.17 and Sea 81-4.21 (only two amino acid differences) and the complete TprK proteins Sea 81-4.120 and Sea 81-4.121 (nine amino acid differences). Furthermore, complete identity in motifs encompassing the whole V4 region can be seen between and within isolates (Fig. (Fig.3).3 Multiple tprK sequences found within an isolate could arise from multiple tprK genes within a single bacterium or from multiple subpopulations within an isolate, with each subpopulation carrying a single tprK gene. The presence of genotypically different bacterial organisms within an isolate is demonstrated by the existence of different tprK gene sequences located in the same locus of the chromosome. We have shown in this study that there are genotypically different bacterial subpopulations present within T. pallidum isolates (Fig. (Fig.4).4 Several observations are consistent with the existence of subpopulations in T. pallidum. The natural history of syphilis (latent infection interrupted by episodes of active disease), the inability of some T. pallidum to be opsonized for phagocytosis (23), and resistance to high titers of specific antibodies in vivo during secondary syphilis may be explained by genetic mechanisms such as phase and antigenic variation of the TprK antigens. Alternatively, tissue tropism, such as neuroinvasive capacity, could originate from the variable regions of surface-exposed TprK antigens. Lastly, cross-immunity studies have demonstrated that infection with a particular T. pallidum isolate will induce complete protection only against reinfection with the homologous strain, while protection against other isolates is absent or partial (31) (S. A. Lukehart et al., unpublished data). This observation suggests that there is heterogeneity among the protective antigens of different isolates, which might be explained in part by the variability of TprK. It is intriguing that there is only a single-copy tprK gene in the Nichols strain (16), whereas all other examined isolates from our treponemal strain bank have multiple tprK sequences. Because the Nichols strain has been maintained by passage in rabbits for more than 80 years, it may have adapted for survival in rabbit tissues by expressing only a single TprK molecule. Alternatively, multiple intratesticular passages may have led to selection of a single clone from an original population with differing TprK molecules. The other isolates that we examined have been passed in rabbits only a few times relative to the Nichols strain. It is noteworthy that there are sequence differences in the tprK gene at both the DNA and predicted protein level between two Nichols strains maintained in different laboratories. These two Nichols “strains” were both originally obtained from James Miller at the University of California at Los Angeles in 1978 (to La Jolla and then to Houston) and 1979 (to Seattle) and have been propagated separately since that time. Although highly homologous, there are some reproducible differences between the two Nichols strains (Fig. (Fig.4),4 This study describes the identification of multiple, heterogeneous tprK genes in non-Nichols T. pallidum strains. These tprK genes potentially encode surface-exposed variable proteins as predicted by their very high DNA and amino acid homology with the Nichols TprK antigen, which has been functionally identified as a surface-exposed molecule because it is the target of opsonic antibodies in intact treponemes. These findings invite new research that may lead to a greater understanding of the mechanisms of syphilis pathogenesis and, particularly, immune evasion. The precise functional significance of the multiple variable Tpr K antigens in T. pallidum and the molecular mechanisms that generate tprK diversity are still unclear. ACKNOWLEDGMENTS We thank Sally Post for manuscript preparation and Lynn Barrett for confirmatory independent sequencing of tprK from the Nichols strain. This study was supported by Public Health Service grants AI42143 and AI34616 from the National Institutes of Health (S.A.L.) and Sexually Transmitted Diseases Cooperative Research Center New Investigator Award AI31448 from the National Institutes of Health (A.C.-L.). REFERENCES 1. Akins D R, Robinson E, Shevchenko D, Elkins C, Cox D L, Radolf J D. Tromp1, a putative rare outer membrane protein, is anchored by an uncleaved signal sequence to the Treponema pallidum cytoplasmic membrane. J Bacteriol. 1997;179:5076–5086. [PubMed] 2. Baker-Zander S A, Lukehart S A. Macrophage-mediated killing of opsonized Treponema pallidum. J Infect Dis. 1992;165:69–74. [PubMed] 3. Blanco D R, Champion C I, Exner M M, Shang E S, Skare J T, Hancock R E, Miller J N, Lovett M A. Recombinant Treponema pallidum rare outer membrane protein 1 (Tromp1) expressed in Escherichia coli has porin activity and surface antigenic exposure. J Bacteriol. 1996;178:6685–6692. [PubMed] 4. Blanco D R, Champion C I, Lewinski M A, Shang E S, Simkins S G, Miller J N, Lovett M A. Immunization with Treponema pallidum outer membrane vesicles induces high-titer complement-dependent treponemicidal activity and aggregation of T. pallidum rare outer membrane proteins (TROMPs). J Immunol. 1999;163:2741–2746. [PubMed] 5. Blanco D R, Miller J N, Lovett M A. Surface antigens of the syphilis spirochete and their potential as virulence determinants. Emerg Infect Dis. 1997;3:11–20. [PubMed] 6. Blanco D R, Walker E M, Haake D A, Champion C I, Miller J N, Lovett M A. Complement activation limits the rate of in vitro treponemicidal activity and correlates with antibody-mediated aggregation of Treponema pallidum rare outer membrane protein. J Immunol. 1990;144:1914–1921. [PubMed] 7. Cameron C E, Castro C, Lukehart S A, Van Voorhis W C. Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase. Infect Immun. 1998;66:5763–5770. [PubMed] 8. Centurion-Lara A, Castro C, Barrett L, Cameron C, Mostowfi M, Van Voorhis W C, Lukehart S A. Treponema pallidum major sheath protein homologue TprK is a target of opsonic antibody and the protective immune response. J Exp Med. 1999;189:647–656. [PubMed] 9. Centurion-Lara A, Castro C, Castillo R, Shaffer J M, Van Voorhis W C, Lukehart S A. The flanking region sequences of the 15-kDa lipoprotein gene differentiate pathogenic treponemes. J Infect Dis. 1998;177:1036–1040. [PubMed] 10. Champion C I, Blanco D R, Exner M M, Erdjument-Bromage H, Hancock R E, Tempst P, Miller J N, Lovett M A. Sequence analysis and recombinant expression of a 28-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp2). J Bacteriol. 1997;179:1230–1238. [PubMed] 11. Cox D L, Akins D R, Porcella S F, Norgard M V, Radolf J D. Treponema pallidum in gel microdroplets: a novel strategy for investigation of treponemal molecular architecture. Mol Microbiol. 1995;15:1151–1164. [PubMed] 12. Cox D L, Chang P, McDowall A W, Radolf J D. The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun. 1992;60:1076–1083. [PubMed] 13. Deka R K, Lee Y H, Hagman K E, Shevchenko D, Lingwood C A, Hasemann C A, Norgard M V, Radolf J D. Physicochemical evidence that Treponema pallidum TroA is a zinc-containing metalloprotein that lacks porin-like structure. J Bacteriol. 1999;181:4420–4423. [PubMed] 14. Egli C, Leung W K, Muller K H, Hancock R E, McBride B C. Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect Immun. 1993;61:1694–1699. [PubMed] 15. Fenno J C, Muller K H, McBride B C. Sequence analysis, expression, and binding activity of recombinant major outer sheath protein (Msp) of Treponema denticola. J Bacteriol. 1996;178:2489–2497. [PubMed] 16. Fraser C M, Norris S J, Weinstock G M, White O, Sutton G G, Dodson R, Gwinn M, Hickey E K, Clayton R, Ketchum K A, Sodergren E, Hardham J M, McLeod M P, Salzberg S, Peterson J, Khalak H, Richardson D, Howell J K, Chidambaram M, Utterback T, McDonald L, Artiach P, Bowman C, Cotton M D, Venter J C, et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science. 1998;281:375–388. [PubMed] 17. Hardham J M, Stamm L V, Porcella S F, Frye J G, Barnes N Y, Howell J K, Mueller S L, Radolf J D, Weinstock G M, Norris S J. Identification and transcriptional analysis of a Treponema pallidum operon encoding a putative ABC transport system, an iron-activated repressor protein homolog, and a glycolytic pathway enzyme homolog. Gene. 1997;197:47–64. [PubMed] 18. Lee Y H, Deka R K, Norgard M V, Radolf J D, Hasemann C A. Treponema pallidum TroA is a periplasmic zinc-binding protein with a helical backbone. Nat Struct Biol. 1999;6:628–633. [PubMed] 19. Lewinski M A, Miller J N, Lovett M A, Blanco D R. Correlation of immunity in experimental syphilis with serum-mediated aggregation of Treponema pallidum rare outer membrane proteins. Infect Immun. 1999;67:3631–3636. [PubMed] 20. Lukehart S A, Baker-Zander S A, Lloyd R M, Sell S. Characterization of lymphocyte responsiveness in early experimental syphilis. II. Nature of cellular infiltration and Treponema pallidum distribution in testicular lesions. J Immunol. 1980;124:461–467. [PubMed] 21. Lukehart S A, Baker-Zander S A, Lloyd R M C, Sell S. Immunology and pathogenesis of syphilis. In: Quinn T C, Gallin J I, Fauci A S, editors. Sexually transmitted diseases. Vol. 8. New York, N.Y: Raven Press; 1992. pp. 141–163. 22. Lukehart S A, Baker-Zander S A, Sell S. Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens. J Immunol. 1980;124:454–460. [PubMed] 23. Lukehart S A, Shaffer J M, Baker-Zander S A. A subpopulation of Treponema pallidum is resistant to phagocytosis: possible mechanism of persistence. J Infect Dis. 1992;166:1449–1453. [PubMed] 24. Norris S J, Alderete J F, Axelsen N H, Bailey M J, Baker-Zander S A, Baseman J B, Bassford P J, Baughn R E, Cockayne A, Hanff P A, Hindersson P, Larsen S A, Lovett M A, Lukehart S A, Miller J N, Moskophidis M A, Muller F, Norgard M V, Penn C W, Stamm L V, van Embden J D, Wicher K. Identity of Treponema pallidum subsp. pallidum polypeptides: correlation of sodium dodecyl sulfate-polyacrylamide gel electrophoresis results from different laboratories. Electrophoresis. 1987;8:77–92. 25. Radolf J D. Role of outer membrane architecture in immune evasion by Treponema pallidum and Borrelia burgdorferi. Trends Microbiol. 1994;2:307–311. [PubMed] 26. Radolf J D. Treponema pallidum and the quest for outer membrane proteins. Mol Microbiol. 1995;16:1067–1073. [PubMed] 27. Radolf J D, Norgard M V. Pathogen specificity of Treponema pallidum subsp. pallidum integral membrane proteins identified by phase partitioning with Triton X-114. Infect Immun. 1988;56:1825–1828. [PubMed] 28. Radolf J D, Norgard M V, Schulz W W. Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum. Proc Natl Acad Sci USA. 1989;86:2051–2055. [PubMed] 29. Shevchenko D V, Sellati T J, Cox D L, Shevchenko O V, Robinson E J, Radolf J D. Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog. Infect Immun. 1999;67:2266–2276. [PubMed] 30. Stamm L V, Greene S R, Bergen H L, Hardham J M, Barnes N Y. Identification and sequence analysis of Treponema pallidum tprJ, a member of a polymorphic multigene family. FEMS Microbiol Lett. 1998;169:155–163. [PubMed] 31. Turner T B, Hollander D H. Biology of the treponematoses. Geneva, Switzerland: World Health Organization; 1957. 32. Walker E M, Zampighi G A, Blanco D R, Miller J N, Lovett M A. Demonstration of rare protein in the outer membrane of Treponema pallidum subsp. pallidum by freeze-fracture analysis. J Bacteriol. 1989;171:5005–5011. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
J Immunol. 1980 Jan; 124(1):461-7.
[J Immunol. 1980]J Infect Dis. 1992 Jan; 165(1):69-74.
[J Infect Dis. 1992]Trends Microbiol. 1994 Sep; 2(9):307-11.
[Trends Microbiol. 1994]Infect Immun. 1992 Mar; 60(3):1076-83.
[Infect Immun. 1992]Mol Microbiol. 1995 Mar; 15(6):1151-64.
[Mol Microbiol. 1995]Infect Immun. 1988 Jul; 56(7):1825-8.
[Infect Immun. 1988]Proc Natl Acad Sci U S A. 1989 Mar; 86(6):2051-5.
[Proc Natl Acad Sci U S A. 1989]J Exp Med. 1999 Feb 15; 189(4):647-56.
[J Exp Med. 1999]Science. 1998 Jul 17; 281(5375):375-88.
[Science. 1998]FEMS Microbiol Lett. 1998 Dec 1; 169(1):155-63.
[FEMS Microbiol Lett. 1998]Infect Immun. 1993 May; 61(5):1694-9.
[Infect Immun. 1993]J Bacteriol. 1996 May; 178(9):2489-97.
[J Bacteriol. 1996]J Immunol. 1980 Jan; 124(1):454-60.
[J Immunol. 1980]J Infect Dis. 1998 Apr; 177(4):1036-40.
[J Infect Dis. 1998]Science. 1998 Jul 17; 281(5375):375-88.
[Science. 1998]J Exp Med. 1999 Feb 15; 189(4):647-56.
[J Exp Med. 1999]Science. 1998 Jul 17; 281(5375):375-88.
[Science. 1998]J Exp Med. 1999 Feb 15; 189(4):647-56.
[J Exp Med. 1999]J Infect Dis. 1992 Dec; 166(6):1449-53.
[J Infect Dis. 1992]Science. 1998 Jul 17; 281(5375):375-88.
[Science. 1998]J Infect Dis. 1998 Apr; 177(4):1036-40.
[J Infect Dis. 1998]